Japan is in the process of approving Moderna Inc.'s COVID-19 vaccine for use on adolescents aged 12 to 17, the government's top spokesman said Friday.A panel at the Ministry of Health, Labor and Welfare will consider lowering the age limit for the shot, which has already been given the green light for people aged 18 and older, "if the efficacy and safety is confirmed and the guidelines are amended," Chief Cabinet Secretary Katsunobu Kato said at a press conference.Moderna's Japanese partner Takeda Pharmaceutical Co. is already in talks with the ministry, Kato said, setting up the vaccine to…READ FULL ARTICLE
